Your browser doesn't support javascript.
loading
Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study.
Candal-Pedreira, Cristina; Ruano-Ravina, Alberto; Calvo de Juan, Virginia; Cobo, Manuel; Trigo, José Manuel; Carcereny, Enric; Cucurull, Marc; López Castro, Rafael; Solís García, Eduardo; Sánchez-Gastaldo, Amparo; Massutí, Bartomeu; Rodríguez-Abreu, Delvys; Estival, Anna; Guirado Risueño, María; Pamiés Ramón, María; García Campelo, Rosario; Alonso-Jáudenes, Guillermo; Camps, Carlos; Del Barco Morillo, Edel; González Ojea, Clara; Dómine, Manuel; Sanchez-Hernandez, Alfredo; Bosch-Barrera, Joaquím; Sala González, María Ángeles; Provencio, Mariano.
Affiliation
  • Candal-Pedreira C; Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Ruano-Ravina A; Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela), Santiago de Compostela, Spain.
  • Calvo de Juan V; Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Cobo M; Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela), Santiago de Compostela, Spain.
  • Trigo JM; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública), Madrid, Spain.
  • Carcereny E; Oncology Department, Puerta de Hierro University Teaching Hospital, Majadahonda, Spain.
  • Cucurull M; UGC Medical Oncology Intercenters, Regional and Virgen de la Victoria University Teaching Hospitals, IBIMA, Malaga, Spain.
  • López Castro R; UGC Medical Oncology Intercenters, Regional and Virgen de la Victoria University Teaching Hospitals, IBIMA, Malaga, Spain.
  • Solís García E; Medical Oncology Department, Catalonian Oncology Institute, Badalona-Germans Trias i Pujol Hospital B-ARGO Group, Badalona, Spain.
  • Sánchez-Gastaldo A; Medical Oncology Department, Catalonian Oncology Institute, Badalona-Germans Trias i Pujol Hospital B-ARGO Group, Badalona, Spain.
  • Massutí B; Medical Oncology Section, Valladolid University Clinical Teaching Hospital, Valladolid, Spain.
  • Rodríguez-Abreu D; Medical Oncology Section, Valladolid University Clinical Teaching Hospital, Valladolid, Spain.
  • Estival A; Virgen del Rocio University Teaching Hospital, Seville, Spain.
  • Guirado Risueño M; Dr Balmis University Teaching Hospital, ISABIAL, Alicante, Spain.
  • Pamiés Ramón M; Gran Canaria Island Hospital, Las Palmas de Gran Canaria, Spain.
  • García Campelo R; Gran Canaria Island Hospital, Las Palmas de Gran Canaria, Spain.
  • Alonso-Jáudenes G; Department of Oncology, Elche University General Teaching Hospital, Elche, Spain.
  • Camps C; Department of Oncology, Elche University General Teaching Hospital, Elche, Spain.
  • Del Barco Morillo E; Department of Oncology, A Coruña University Teaching Hospital Complex, Corunna, Spain.
  • González Ojea C; Department of Oncology, A Coruña University Teaching Hospital Complex, Corunna, Spain.
  • Dómine M; Medical Oncology Department, Valencia University General Teaching Hospital, Valencia, Spain.
  • Sanchez-Hernandez A; Department of Medicine, University of Valencia, Valencia, Spain.
  • Bosch-Barrera J; Consortium for Biomedical Research in Cancer (Centro de Investigación Biomédica en Red Cáncer), Madrid, Spain.
  • Sala González MÁ; Medical Oncology Department, Salamanca University Healthcare Complex-IBSAL, Salamanca, Spain.
  • Provencio M; Álvaro Cunqueiro University Teaching Hospital, Vigo, Spain.
ERJ Open Res ; 9(6)2023 Nov.
Article de En | MEDLINE | ID: mdl-38076676
ABSTRACT

Objectives:

The aim of the study was to ascertain the percentage of Spanish lung cancer cases that would fulfil the lung cancer screening inclusion criteria recommended by the United States Preventive Service Task Force (USPSTF) in 2013 and 2021.

Methods:

A cross-sectional study was carried out. All lung cancer cases registered in the Thoracic Tumor Registry with data on date of birth, date of diagnosis, smoking habit, number of pack-years and time elapsed since smoking cessation were included.

Results:

The study included 15 006 patients diagnosed with lung cancer in Spain between 2016 and 2022. Eligibility to participate in screening increased from 53.7% to 63.5% (an increase of 9.8%) according to the 2013 and 2021 recommendations, respectively. The percentage of eligible men rose by 9.2 percentage points with the 2021 versus 2013 recommendations, whereas this rise was 11.5 percentage points in women. Under the 2021 recommendations, 36.6% of women and 5.3% of men would not have fulfilled the screening inclusion criteria due to being never-smokers; 14.9% of women and 11.0% of men would not have fulfilled the age criterion; and 27.0% of ex-smokers among women compared to 35.6% among men would not have been eligible due to >15 years having elapsed since smoking cessation.

Conclusions:

In Spain, over one-third of lung cancer cases could not be detected through screening, by virtue of not meeting the most recent inclusion criteria stated by the USPSTF. The degree of fulfilment in a potential nationwide screening programme should be analysed, with the aim of establishing inclusion criteria in line with each country's context.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: ERJ Open Res Année: 2023 Type de document: Article Pays d'affiliation: Espagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: ERJ Open Res Année: 2023 Type de document: Article Pays d'affiliation: Espagne
...